Crossref
journal-article
Elsevier BV
Medical Hypotheses (78)
References
40
Referenced
13
10.1097/00005072-199712000-00001
/ J Neuropathol Exp Neurol / Aging-associated changes in human brain by Mrak (1997){'key': '10.1054/mehy.2000.1212_RF2', 'first-page': '63', 'article-title': 'Penetration of solutes, viruses, and cells across the blood-brain barrier', 'volume': '202', 'author': 'Brightman', 'year': '1995', 'journal-title': 'Curr Topics Microbiol Immunol'}
/ Curr Topics Microbiol Immunol / Penetration of solutes, viruses, and cells across the blood-brain barrier by Brightman (1995)10.1212/WNL.29.6.809
/ Neurology / Brain aluminum in aging and Alzheimer’s disease by McDermott (1995)10.1016/S0301-0082(98)00069-0
/ Prog Neurobiol / Reactive microgliosis by Streit (1999)10.1016/S0304-3940(97)00708-8
/ Neurosci Lett / Glial reaction in the hippocampal formation is highly concentrated with aging in human brain by David (1997)10.1146/annurev.iy.12.040194.001041
/ Annu Rev Immunol / Function and activation of NF-κB in the immune system by Baeuerle (1994)10.1016/S0952-7915(99)00050-3
/ Curr Opin Immunol / NF-κB and the innate immune response by Hatada (2000)10.1016/S0952-7915(98)80024-1
/ Curr Opin Immunol / An ancient system of host defense by Medzhitov (1998)10.1002/(SICI)1097-4547(19980901)53:5<583::AID-JNR8>3.0.CO;2-5
/ J Neurosci Res / Strong nuclear factor -κB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer’s disease superior temporal lobe neocortex by Lukiw (1998){'key': '10.1054/mehy.2000.1212_RF10', 'series-title': 'Molecular Neurobiology: Mechanisms common to brain, skin, and immune system. New York: Wiley-Liss Inc', 'first-page': '57', 'article-title': 'The involvement of amyloid associated proteins in the formation of β-protein filaments in Alzheimer’s disease', 'author': 'Potter', 'year': '1994'}
/ Molecular Neurobiology: Mechanisms common to brain, skin, and immune system. New York: Wiley-Liss Inc / The involvement of amyloid associated proteins in the formation of β-protein filaments in Alzheimer’s disease by Potter (1994)10.1016/S0306-4522(96)00553-2
/ Neuroscience / Amyloid precursor protein protect neurons of transgenic mice against acute and chronic excitation injuries in vivo by Masliah (1997){'key': '10.1054/mehy.2000.1212_RF12', 'first-page': '795', 'article-title': 'The role of the amyloid protein precursor (APP) in Alzheimer’s disease. Does the normal function of APP explain the topography of neurodegeneration?', 'volume': '23', 'author': 'Small', 'year': '1998', 'journal-title': 'Neurosci Res'}
/ Neurosci Res / The role of the amyloid protein precursor (APP) in Alzheimer’s disease. Does the normal function of APP explain the topography of neurodegeneration? by Small (1998)10.1073/pnas.95.21.12683
/ Proc Natl Acad Sci U.S.A. / Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice by Meziane (1998)10.1097/00001756-199802160-00029
/ Neuroreport / Post-ischemic changes in the expression of Alzheimer’s APP isoforms in rat cerebral cortex by Kim (1998)10.1074/jbc.274.10.6421
/ J Biol Chem / Translation of the Alzheimer’s amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences by Rogers (1999)10.1126/science.286.5440.735
/ Science / β-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE by Vassar (1999)10.1074/jbc.274.45.32301
/ J Biol Chem / Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer’s Amyloid β-peptide by microglial cells by Chung (1999)10.1038/77399
/ Nature Med / Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition by Iwata (2000)10.1006/exnr.1999.7055
/ Exp Neurol / et al., Inhibition of Alzheimer’s β-amyloid induced vasoactivity and proinflammatory response in microglia by cGMP-dependent mechanism by Paris (1999)10.1016/S0006-8993(97)01215-8
/ Brain Res / Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer’s disease by Wegrzyniak (1998)10.1007/s000180050107
/ Cel Mol Life Sci / The molecular basis of amyloidosis by Serpell (1997)10.1006/exnr.1993.1199
/ Exp Neurol / Beta-amyloid of Alzheimer’s disease induces reactive gliosis that inhibits axonal outgrowth by Canning (1993)10.1006/exnr.1994.1185
/ Exp Neurol / Regional differences in reactive gliosis induced by substrate-bound β-amyloid by Höke (1994)10.1073/pnas.92.6.1989
/ Proc Natl Acad Sci USA / Amyloid peptides are toxic via a common oxidative mechanism by Schubert (1995)10.1046/j.1471-4159.1998.70052212.x
/ J Neurochem / Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress by Smith (1998)10.1074/jbc.274.22.15493
/ J Biol Chem / β-amyloid activates O2forming NADPH oxidase in microglia, monocytes, and neutrophils by Bianca (1999)10.1038/374647a0
/ Nature / Activation of microglial cells by β-amyloid protein and interferon-γ by Meda (1995)10.1016/S0006-8993(99)01492-4
/ Brain Res / Beta (1–40) amyloid peptide injection into the nucleus basalis of rats induces microglia reaction and enhances cortical gamma-aminobutyric acid release in vivo by Scali (1999)10.1097/00001756-199705260-00033
/ Neuroreport / Perivascular astrocytes within Alzheimer’s disease plaques by Cullen (1997)10.1016/S0306-4522(98)00680-0
/ Neuroscience / Interleukin-1β activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer’s disease by Casamenti (1999)10.1073/pnas.89.21.10016
/ Proc Natl Acad Sci USA / Complement activation by β-amyloid in Alzheimer’s disease by Cooper (1992)10.1097/00001756-199711100-00009
/ Neuroreport / Complement activation by cross-linked truncated and chimeric full-length β-amyloid by D. (1997)10.1016/S0197-4580(99)00020-2
/ Neurobiol Aging / The mouse C1q A-chain sequence alters beta-amyloid-induced complement activation by Webster (1999)10.1006/exnr.1999.7199
/ Exp Neurol / Cytokines associated with amyloid plaques in Alzheimer’s disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor by Veerhuis (1999)10.1046/j.1523-1747.2000.00841.x
/ J Investig Dermatol / Synthesis of complement components C3 and factor B in human keratinocytes is differentially regulated by cytokines by Pasch (2000)10.1073/pnas.95.10.5795
/ Proc Natl Acac Sci USA / Amyloid β peptide stimulates nitric oxide production in astrocytes through an NF-κB-dependent mechanism by Akama (1998)10.1016/S0006-8993(99)01804-1
/ Brain Res / Glial-derived proteins activate cultured astrocytes and enhance beta amyloid-induced glial activation by Hu (1999)10.1074/jbc.273.33.20967
/ J Biol Chem / Macrophage colony-stimulating factor augments β-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells by Murphy (1998)10.1016/S0165-5728(98)00188-X
/ J Neuroimmunol / Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with β-amyloid[25–35] by Meda (1999)10.1073/pnas.92.23.10738
/ Proc Natl Acad Sci USA / Amyloid β peptide potentiates cytokine secretion by interleukin-1β-activated human astrocytoma cells by Gitter (1995)
Dates
Type | When |
---|---|
Created | 22 years, 11 months ago (Sept. 19, 2002, 11:33 a.m.) |
Deposited | 6 years, 4 months ago (April 11, 2019, 3:27 p.m.) |
Indexed | 1 year, 9 months ago (Nov. 17, 2023, 7:43 p.m.) |
Issued | 24 years, 6 months ago (March 1, 2001) |
Published | 24 years, 6 months ago (March 1, 2001) |
Published Print | 24 years, 6 months ago (March 1, 2001) |